Stock A115450 HLB THERAPEUTICS CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News HLB Therapeutics Co.,Ltd.

Equities

A115450

KR7115450009

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 03/06/2024 am IST 		5-day change 1st Jan Change
7,630 KRW -9.92% Intraday chart for HLB Therapeutics Co.,Ltd. -5.45% +74.00%
16/05 HLB Therapeutics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
01/04 HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.
CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
HLB Life Science Co., Ltd. announced that it has received KRW 8.3 billion in funding from HLB Therapeutics Co.,Ltd.
CI
HLB Life Science Co., Ltd. announced that it expects to receive KRW 8.3 billion in funding from HLB Therapeutics Co.,Ltd.
CI
Panagene Inc. announced that it expects to receive KRW 56.599994061 billion in funding from a group of investors
CI
Panagene Inc. announced that it expects to receive KRW 46.068324061 billion in funding from HLB Co., Ltd., HLB Investment Co., Ltd., HLB bioStep Co.,Ltd., HLB innoVation Co.,Ltd., HLB Therapeutics Co.,Ltd.
CI
HLB Therapeutics Co.,Ltd. announced that it has received KRW 2.5 billion in funding
CI
HLB Therapeutics Co.,Ltd. announced that it has received KRW 5 billion in funding
CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
RegeneRx Biopharmaceuticals, Inc. - First Patient Enrolled into U.S. Phase 3 Neurotrophic Keratitis Clinical trial with RGN-259
AQ
HLB innoVation Co.,Ltd. announced that it has received KRW 55.99999522 billion in funding from a group of investors
CI
Oblato, Inc. announced that it has received KRW 18.408 billion in funding from HLB Therapeutics Co.,Ltd.
CI
Oblato, Inc. announced that it expects to receive KRW 18.408 billion in funding from HLB Therapeutics Co.,Ltd.
CI
HLB innoVation Co.,Ltd. announced that it expects to receive KRW 55.99999522 billion in funding from a group of investors
CI
HLB Therapeutics Co.,Ltd. announced that it has received KRW 13.0088 billion in funding from HLB Co., Ltd.
CI
HLB Therapeutics to Raise 13 Billion Won via Stock Sale
MT
HLB Therapeutics Co.,Ltd. announced that it expects to receive KRW 13.0088 billion in funding from HLB Co., Ltd.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A115450 Stock
  4. News HLB Therapeutics Co.,Ltd.